Vaginal Microbiota Among Postmenopausal Women
The Role of Vaginal Microbiota in Symptoms of Vaginal Dryness in Postmenopausal Women
2 other identifiers
observational
16
1 country
1
Brief Summary
It is known that vaginal bacteria have an impact upon the health status of the host, in some cases protecting against infection and in other cases causing infection, depending on the bacterial types present. This study will compare the composition of vaginal bacteria to symptoms of vaginal dryness in order to try and identify if certain bacteria might cause some of the problems associated with vaginal dryness among post-menopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2010
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 9, 2010
CompletedFirst Posted
Study publicly available on registry
March 10, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedDecember 17, 2010
December 1, 2010
6 months
March 9, 2010
December 16, 2010
Conditions
Study Arms (2)
Vaginal Dryness
Non-vaginal dryness
Eligibility Criteria
Postmenopausal women
You may qualify if:
- Between 30 and 80 years old.
- Postmenopausal = 12 months of spontaneous amenorrhea or 6 months of spontaneous amenorrhea with serum FSH levels \> 40 mIU/ml or 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy.
- Prepared not to take hormone replacement therapy during 8 weeks follow-up and not taking estrogen alone or estrogen/progestin containing drug products at the time of screening.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Victoria Family Medical Center
London, Ontario, ON N5Z, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Gregor Reid, PhD
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 9, 2010
First Posted
March 10, 2010
Study Start
January 1, 2010
Primary Completion
July 1, 2010
Study Completion
July 1, 2010
Last Updated
December 17, 2010
Record last verified: 2010-12